Cision Announces Sale of Help A Reporter Out (HARO) to Featured.com

2025-04-17 Cision Ltd. HaiPress

CHICAGO,April 15,2025 -- Cision,a global leader in media intelligence and communications solutions,today announced the sale of its Help A Reporter Out (HARO) platform to Featured.com.

Originally launched in 2008 and acquired by Cision through its merger with Vocus in 2014,HARO provided a long-standing service connecting journalists with expert sources. The sale of HARO reflects Cision's continued focus on strengthening and investing in its core product suite,which includes CisionOne,Brandwatch,and PR Newswire (PRN).

"Cision confirms that it no longer offers the Help A Reporter Out or Connectively services as part of its product suite," said Jim Daxner,Chief Product Officer & Head of Strategy at Cision. "We are focused on advancing our core platforms — CisionOne,and PRN — which are critical to delivering powerful,integrated communications solutions for our customers."

Following the rebranding of HARO to Connectively in 2024 and its subsequent discontinuation,Cision made the decision to divest the asset to an external party. Featured.com was identified as a well-aligned partner to take ownership of the platform.

The transaction allows Cision to concentrate its resources and innovation efforts on its core technology platform strategy. With CisionOne delivering a next-generation media intelligence platform,Brandwatch leading in consumer intelligence and social media management,and PR Newswire continuing as the world's largest press release distribution network,Cision remains committed to enabling communications professionals to effectively manage and measure media impact.

To learn more about Cision's solutions,visit www.cision.com.

About Cision

Cision is the global leader in consumer and media intelligence,engagement,and communication solutions. We equip PR and corporate communications,marketing,and social media professionals with the tools they need to excel in today's data-driven world. Our deep expertise,exclusive data partnerships,and award-winning products,including CisionOne,and PR Newswire,enable over 75,000 companies and organizations,including 84% of the Fortune 500,to see and be seen,understand and be understood by the audiences that matter most to them.

For media inquiries,please contact:


Cision Public Relations: CisionPR@cision.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

2The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

6MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

©copyright 2009-2020 Singapore Info Map